SCHEMBL5322267

SCHEMBL5322267

NC(=O)c1cccc2c1OCC=C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.50
TRPA1 O75762 3/20 0.42
CYP2B6 P20813 1/20 0.41
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
GLA P06280 1/20 0.36
METAP2 P50579 1/20 0.34
GAA P10253 1/20 0.34
AURKA O14965 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30066970 1.00 PARP1 (0.50) PARP1TRPA1CYP2B6ALDH1A1KDM4E
Succinic Acid SCHEMBL5320883 0.91 PARP1 (0.43) PARP1TRPA1CYP2B6ALDH1A1KDM4E
SCHEMBL27845712 0.86 CYP2B6 (0.48) PARP1TRPA1CYP2B6ALDH1A1KDM4E
SCHEMBL30629173 0.85 CYP2B6 (0.42) PARP1TRPA1CYP2B6ALDH1A1KDM4E
SCHEMBL1748858 0.85 CYP2B6 (0.42) PARP1TRPA1CYP2B6ALDH1A1KDM4E
SCHEMBL5321524 0.84 PARP1 (0.38) PARP1TRPA1ALDH1A1KDM4EMAPT
Hydrochloric Acid SCHEMBL6245847 0.83 CYP2B6 (0.41) PARP1TRPA1CYP2B6ALDH1A1KDM4E
SCHEMBL31058480 0.83 CYP2B6 (0.39) PARP1CYP2B6ALDH1A1KDM4EMAPT
SCHEMBL27383030 0.80 TRPA1 (0.46) TRPA1CYP2B6ALDH1A1KDM4EHSD17B10
SCHEMBL30629212 0.76 CYP2B6 (0.39) PARP1CYP2B6CYP1A1CYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233087-A1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS Axovant Sciences GmbH (DE) 2017-10-25 EP claimed
WO-2016100184-A1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS FORUM PHARMACEUTICALS, INC. (US) 2016-06-23 WO claimed
CN-117015530-A Urolithin derivatives and methods of use thereof 范徳利亚股份公司 2023-11-07 CN disclosed
CN-114401952-A Substituted cycloalkyl compounds as modulators of integrated stress pathways 卡里科生命科学有限责任公司 2022-04-26 CN disclosed
EP-3233087-A1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS Axovant Sciences GmbH (DE) 2017-10-25 EP disclosed
WO-2016100184-A1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS FORUM PHARMACEUTICALS, INC. (US) 2016-06-23 WO disclosed
WO-2007096352-A1 5-AMINO-6-BROMO-N-{ [1- (TETRAHYDR0-2H-PYRAN-4-YLMETHYL) -4-PIPERIDINYL] METHYL}-3, 4 -DIHYDRO-2H-CHROMENE-8-CARBOXAMIDE AS 5-HT4 RECEPTOR AGONIST GLAXO GROUP LIMITED (GB) 2007-08-30 WO disclosed
CN-1300277-A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them ADIR (FR) 2001-06-20 CN disclosed